ACON (Aclarion Corporation) Rasio tanggungan utang jangka dawa marang modal

The price action of Aclarion (ACON), whose indicator stands at 0.00, reflects the business development of the AI diagnostics sector. The company's returns are constrained by the slow adoption of back pain analysis methods and the costs associated with data arrays. Cloud infrastructure in the US with secure communication channels guarantees service stability, while current software implementations for the precise recognition of chronic pathologies drive growth.

Aclarion develops innovative diagnostic software that requires significant investment in patenting and integration into US insurance systems. An analysis of the long-term debt-to-equity structure allows for an assessment of the company's reliance on borrowed funds with maturities exceeding one year. This metric captures the share of long-term loans within the equity, revealing the aggressiveness of management's financial strategy. The trend in this long-term debt-to-equity structure signals overpayment risks amid rising interest rates, which directly impacts the stability of the issuer's market capitalization.